ANGLE plc (LON:AGL – Get Free Report)’s share price dropped 13.2% during mid-day trading on Wednesday . The company traded as low as GBX 2.56 ($0.03) and last traded at GBX 2.56 ($0.03). Approximately 1,333,199 shares were traded during mid-day trading, a decline of 16% from the average daily volume of 1,580,736 shares. The stock had previously closed at GBX 2.95 ($0.04).
ANGLE Price Performance
The business’s 50-day moving average price is GBX 4.14 and its 200 day moving average price is GBX 6.33. The company has a market capitalization of £8.13 million, a P/E ratio of -0.53 and a beta of 0.22. The company has a quick ratio of 6.18, a current ratio of 5.19 and a debt-to-equity ratio of 17.22.
ANGLE (LON:AGL – Get Free Report) last posted its earnings results on Tuesday, September 9th. The company reported GBX (2.87) earnings per share for the quarter. ANGLE had a negative return on equity of 76.01% and a negative net margin of 890.91%. Analysts anticipate that ANGLE plc will post -8.6599997 EPS for the current fiscal year.
ANGLE Company Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
Featured Stories
- Five stocks we like better than ANGLE
- How to Most Effectively Use the MarketBeat Earnings Screener
- 2 Ways to Trade Qualcomm Ahead of November’s Earnings
- The Role Economic Reports Play in a Successful Investment Strategy
- Lululemon: 2 Signs the Bottom Is In, and 1 Sign It Isn’t
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Got 1K to Invest? These 3 Stocks Are Still Attractive Buys
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.